CAS: 425-61-6; 2,2,3,3-Tetrafluorobutane-1,4-Diol

该化合物是一种氟化有机化合物,其特点是在丁烷主干脊上存在四个氟原子和两个氢氧(-OH)组,其分子结构有助于其独特的特性,包括高热稳定性和低挥发性,使其适合化学工业的各种应用;氟原子的存在具有疏水特性,而氢氧基原子组则提高其在极地溶剂中的溶解性;该化合物通常用作氟化聚合物和其他特殊化学品的合成中的一种中间体;此外,该化合物具有低毒性,被认为对环境的影响最小,尽管由于化学反应,建议采取适当的处理和安全措施;其物理特性,如沸点和熔点,受到氟化和氢氧化物的影响,可能影响其阶段行为和与其他物质的相互作用;

结构式图片

相似化合物

76-37-9 1220957-89-0 377-71-9

欧盟法规

C&L通报

上下游产品

diethyl tetrafluorosuccinate dimethyl tetrafluorosuccinate 2,2,3,3-tetrafluorobutane-1,4-diol diacetate perfluorosuccinic difluoride 5,5,6,6-Tetrafluoro-1,3-dioxacycloheptan 3,3,4,4-tetrafluorooxolane 4-((tert-butyldiphenylsilyl)oxy)-2,2,3,3-tetrafluorobutan-1-ol mono-O-benzyl-2,2,3,3-tetrafluorobutane-1,4-diol

合成工艺路线路线简述

    四氟丁二酰氯置于乙醇,Sodium Tetrahydroborate,水,Potassium Hydroxide体系中,化学反应 1.5H,以86.8%的收率获得产物四氟丁二醇
    参考文献:一种由含氟环烯烃制备含氟二元醇的方法
    标题:一种由含氟环烯烃制备含氟二元醇的方法
    摘要:本发明公开了一种由含氟环烯烃制备含氟二元醇的方法,该方法以含氟环烯烃为原料,经氧化剂氧化及强碱处理反应生成含有对应含氟二元羧酸盐的固体混合盐,再经酰氯化试剂作用反应生成对应的含氟二元酰氯,最后含氟二元酰氯在溶剂和催化剂作用下与还原剂发生还原反应,得到对应的含氟二元醇.本发明采用特定的有机溶剂和催化剂,配合其他条件,能够有效促进含氟环烯烃高效率,高收率地反应生成相应的含氟二元醇.该方法具有原料易得,工艺简单,操作方便,耗费成本低等优点,适宜于规模化生产含氟二元醇.

    海关参考信息

    专利信息


    专利号:US-7442802-B2
    优先权日:2002-06-27
    标 题:Cyclooxygenase-2 selective inhibitors, compositions and methods of use
    发明人:BANDARAGE UPUL K; EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; KHANAPURE SUBHASH P; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI
    权利人:NITROMED INC
    摘要:The invention describes novel cyclooxygenase 2 (COX-2) selective inhibitors and novel compositions comprising at least one cyclooxygenase 2 (COX-2) selective inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one COX-2 selective inhibitor, optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor, and/or, optionally, at least one therapeutic agent. The novel cyclooxygenase 2 selective inhibitors of the invention can be optionally nitrosated and/or nitrosylated. The invention also provides methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 selective inhibitors; for facilitating wound healing; for treating and/or preventing renal and/or respiratory toxicity; for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2; and for improving the cardiovascular profile of COX-2 selective inhibitors.

    专利号:US-6812350-B2
    优先权日:2002-06-04
    标题:Synthesis of 3,3,4,4-tetrafluoropyrrolidine and novel dipeptidyl peptidase-IV inhibitor compounds
    发明人:HULIN BERNARD
    权利人:PFIZER
    摘要:The present invention relates to a method of making novel dipeptidyl peptidase-IV (“DPP-IV’) inhibitor compounds useful for treating, inter alia, diseases that are associated with proteins that are subject to processing by DPP-IV, such as Type 2 diabetes mellitus, metabolic syndrome (Syndrome X or insulin resistance syndrome), hyperglycemia, impaired glucose tolerance, glucosuria, metabolic acidosis, cataracts, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, Type 1 diabetes, obesity, hypertension, hyperlipidemia, atherosclerosis, osteoporosis, osteopenia, frailty, bone loss, bone fracture, acute coronary syndrome, infertility due to polycystic ovary syndrome, short bowel syndrome and to prevent disease progression in Type 2 diabetes. The invention also relates to a method of making 3,3,4,4-tetrafluoropyrrolidine, a starting material utilized in the afore-mentioned method for preparing DPP-IV compounds.

    专利号:US-2004002609-A1
    优先权日:2002-06-04
    标题:Synthesis of 3,3,4,4-tetrafluoropyrrolidine and novel dipeptidyl peptidase-IV inhibitor compounds

    专利号:US-2004242898-A1
    优先权日:2002-06-04
    标 题:Synthesis of 3,3,4,4-tetrafluoropyrrolidine and novel dipeptidyl peptidase-IV inhibitor compounds

    专利号:US-11613667-B2
    优先权日:2017-12-26
    标 题:Fluorinate polyacrylate coating composition, the preparation method therefore and use thereof
    发明人:SHI ZHENG; WANG JIANHUI; LU JUNBIAO; XU ZHENGLIN; XING SHILI
    权利人:AKZO NOBEL COATINGS INT BV
    摘要:The embodiments herein relate to a composition of a fluorinated polyurethane acrylate resin and a polyurethane acrylate resin, which, upon curing, is durable and has anti-stain and anti-scratch properties. The preparation of the composition is conducted with a one-pot multicomponent synthesis process, wherein multiple components are put together to carry out reactions simultaneously. The process is especially suitable for industrial scale production, and open for adding additive components to further adjust the performance of the prepared composition. The embodiments herein also relate to oligomers prepared in the synthesis process, as well as the use of the composition or oligomer to form a coating onto a substrate.

    专利号:CN-103524394-A
    优先权日:2012-07-04
    标题:Synthesis method and application of a kind of fluorine-containing nitrogen heterocyclic alkyne liquid crystal compound
    天津众泰材料科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chinatechem.com
    企业联系电话:18222148709👤
    📞天津众泰材料科技有限公司 ⚠️参考联系方式
    联系人:朱经理
    电话:18222148709
    手机:18222148709
    传真:固话 022-83726202
    邮箱:sales15@chinatechem.com
    通信地址: 天津市西青区学府工业区恒通企业港E3栋
    邮编: 300384
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:天津市西青区学府工业区恒通企业港E3栋
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海氟锐医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.fluororing.com
    企业联系电话:021-37787203;18018698069👤
    📞上海氟锐医药科技有限公司 ⚠️参考联系方式
    联系人:金经理
    电话:021-37787203;18018698069
    手机:18018698069
    传真:QQ:3917053946;laurajin@fluororing.com
    邮箱:sales@fluororing.com
    通信地址: 上海车墩镇车新公路185号4幢2层202室
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海车墩镇车新公路185号4幢2层202室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:E. T. McBee, W. F. Marzluff and O. R. Pierce, J. Am. Chem. Soc. 74, 444 (1952).
    参考文献:10.1021/jp056124l
    摘要:Schuh MD, Baldwin MC. Alpha-helix formation in melittin and beta-lactoglobulin A induced by fluorinated dialcohols. J Phys Chem B. 2006 Jun 08;110(22):10903–9.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知